GlassScriptPhysician profile
Chad M Simon
NPI 1871797464
$1,893.14
in general payments reported to CMS, 2019-2025
17 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $176 · 2021: $272 · 2022: $374 · 2023: $320 · 2024: $152 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $612.82 | 2019-2024 | |
| Genzyme Corporation | $385.53 | 2020-2025 | |
| Glaxosmithkline, LLC. | $209.45 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $190.20 | 2019-2024 | Dupixent |
| Acclarent, INC | $68.95 | 2021-2023 | Trudi Nav Cable |
| Novartis Pharmaceuticals Corporation | $51.61 | 2021 | |
| Stryker Corporation | $51.34 | 2019-2023 | Audion Et Dilation System |
| Hikma Pharmaceuticals USA | $50.87 | 2023 | Ryaltris |
| Aerin Medical INC. | $43.40 | 2019-2023 | |
| Inspire Medical Systems, INC. | $36.29 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $33.11 | 2021-2025 | Tezspire |
| Itamar Medical INC | $31.74 | 2023 | Watchpatone |
| Arbor Pharmaceuticals, INC. | $28.95 | 2019 | |
| Smith+Nephew, INC. | $28.05 | 2019 | |
| Hill Dermaceuticals, INC. | $25.80 | 2023 | Tolak |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25.28 | 2022 | |
| Genentech USA, INC. | $19.75 | 2023 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.